Citation Impact

Citing Papers

British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
β-lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity
2013
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Lack of Unique Ciprofloxacin Pharmacokinetic Characteristics in Patients with Cystic Fibrosis
1988
Cytosolic epoxide hydrolase
1988
Ciprofloxacin
1988
Oral vs intravenous antibiotic prophylaxis in elective laparoscopic cholecystectomy—an exploratory trial
2007
Effect of Ciprofloxacin on the Pharmacokinetics and Pharmacodynamics of Warfarin
1996
The genetic toxicity of human carcinogens and its implications
1988 Standout
Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin
2008
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
2007 Standout
The SOS chromotest: a review
1993 Standout
Cerebrospinal Fluid Penetration of High Doses of Intravenous Ciprofloxacin in Meningitis
2000
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Regulation of Renal Organic Anion Transporter 3 (SLC22A8) Expression and Function by the Integrity of Lipid Raft Domains and their Associated Cytoskeleton
2013 Standout
Siloranes in dental composites
2004 Standout
Mutagenic activity of structurally related oxiranes and siloranes in Salmonella typhimurium
2002
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Evaluation of the SOS chromotest
1988
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients
1992
Epoxides: comparison of the induction of SOS repair in Escherichia coli PQ37 and the bacterial mutagenicity in the Ames test
1990
Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review
2015
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Bacterial Biofilm and its Role in the Pathogenesis of Disease
2020 Standout
Stereoselective interaction between the R enantiomer of warfarin and cimetidine.
1986
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks
1985
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A Disease
1994
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study
1991
Prosthetic Joint Infection
2014 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Efficacy and Safety of a Novel Once-Daily Extended-Release Ciprofloxacin Tablet Formulation for Treatment of Uncomplicated Urinary Tract Infection in Women
2005
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Ciprofloxacin concentrations in bone and muscle after oral dosing
1986
Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols
1985

Works of D. Beermann being referenced

Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule)
1989
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf‐capsule.
1990
Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections
1989
Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges
1991
Mutagenicity of structurally related oxiranes derivatives of benzene and its hydrogenated congeners
1981
Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers
1984
Dose- and Sex-Independent Disposition of Ciprofloxacin
1986
Dose- and sex-independent disposition of ciprofloxacin
1984
Liquid Chromatographic Analysis of Ciprofloxacin and Ciprofloxacin Metabolites in Body Fluids
1986
Differential effect of the enantiomers of phenprocoumon and warfarin on the vitamin K1-epoxide/vitamin K1 ratio in rat plasma
1979
A highly sensitive assay for epoxide hydrolase using an endogenous epoxide as substrate: 16α, 17α-epoxyandrost-4-en-3-one
1981
Rankless by CCL
2026